Investor Relations

Overview

Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.

Events & Presentations

Upcoming

More events are coming soon.

FRONT >> Events > View All

Prior

Monday April 6, 2020 at 8:00 AM EDT
Ruxolitinib Cream: Phase 3 Data in Atopic Dermatitis

Monday March 2, 2020 at 11:20 AM EST
Cowen and Company’s 40th Annual Health Care Conference

Thursday February 13, 2020 at 8:00 AM EST
Q4 2019 Incyte Corporation Earnings Conference Call

FRONT >> Events > View All

Investor Contacts

Michael Booth D.Phil
Division VP, Investor Relations & Corporate Responsibility
Phone: 302.498.5914
mbooth@incyte.com

Lauren Ayala, MBA
Senior Director, Investor Relations & Corporate Responsibility
Phone: 302.498.6141
layala@incyte.com

Christine Chiou
Senior Director, Investor Relations
Phone: 302.274.4773
cchiou@incyte.com

Copyright West LLC. Minimum 15 minutes delayed.

04. Sidebar Quicklinks